Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-5 of 15

Journal Article

21/09/2020

Real-world costs of azacitidine treatment in patients with higher-risk myelodysplastic syndromes/low blast-count acute myeloid leukemia

Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. JCO Oncol Pract. 2021; 17(4):e517-25. Epub 2020 Sep 21.

Journal Article

23/04/2020

Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada

Bankar A, Zhao H, Iqbal J, Coxford R, Cheung MC, Mozessohn L, Earle CC, Gupta V. Leuk Lymphoma. 2020; 61(8):1908-19. Epub 2020 Apr 23.

Journal Article

17/04/2020

Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects

Smyth L, Blunt DN, Gatov E, Nagamuthu C, Croxford R, Mozessohn L, Cheung MC. Br J Haematol. 2020; 191(3):396-404. Epub 2020 Apr 17.

Journal Article

08/02/2020

Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the ‘real-world’

Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. Leuk Lymphoma. 2020; 61(6):1445-54. Epub 2020 Feb 8.

Journal Article

17/10/2016

The association of dyslipidemia with chronic lymphocytic leukemia: a population-based study

Mozessohn L, Earle C, Spaner D, Cheng SY, Kumar M, Buckstein R. J Natl Cancer Inst. 2017; 109(3):1-9. Epub 2016 Oct 17.

« Previous 1 2

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Real-world costs of azacitidine treatment in patients with higher-risk myelodysplastic syndromes/low blast-count acute myeloid leukemia

Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada

Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects

Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the ‘real-world’

The association of dyslipidemia with chronic lymphocytic leukemia: a population-based study